Key EU Products

All product information provided is intended for European Union healthcare professionals only. These products may not be available in all Member States of the EU, or in countries outside the EU or may be available under a different trademark; in different strengths; or for different indications. Countries outside the EU may have different regulatory requirements that would call for different information to be available.

Key commercial products in the European Union include:

  • BYDUREON™
  • RISPERDAL® CONSTA®
  • XEPLION®
  • FAMPYRA®

This page is intended for EU healthcare professionals only.